Chronic kidney disease in low- and middle-income countries

被引:178
作者
Stanifer, John W. [1 ,2 ,3 ]
Muiru, Anthony [4 ]
Jafar, Tazeen H. [5 ]
Patel, Uptal D. [1 ,2 ,3 ]
机构
[1] Duke Univ, Dept Med, Div Nephrol, Durham, NC 27705 USA
[2] Duke Univ, Duke Global Hlth Inst, Durham, NC 27710 USA
[3] Duke Univ, Duke Clin Res Inst, Durham, NC 27705 USA
[4] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA
[5] Duke NUS Grad Med Sch, Hlth Serv & Syst Res, Singapore, Singapore
基金
美国国家卫生研究院;
关键词
epidemiology; multidisciplinary; noncommunicable diseases; urbanization; RENAL REPLACEMENT THERAPY; RISK-FACTORS; ADULT-POPULATION; HIGH PREVALENCE; EPIDEMIOLOGY; MANAGEMENT; BURDEN; INDIA; HYPERTENSION; NEPHROPATHY;
D O I
10.1093/ndt/gfv466
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Most of the global burden of chronic kidney disease (CKD) is occurring in low-and middle-income countries (LMICs). As a result of rapid urbanization in LMICs, a growing number of populations are exposed to numerous environmental toxins, high infectious disease burdens and increasing rates of noncommunicable diseases. For CKD, this portends a high prevalence related to numerous etiologies, and it presents unique challenges. A better understanding of the epidemiology of CKD in LMICs is urgently needed, but this must be coupled with strong public advocacy and broad, collaborative public health efforts that address environmental, communicable, and non-communicable risk factors.
引用
收藏
页码:868 / 874
页数:7
相关论文
共 79 条
  • [21] Training nephrologists from developing countries: does it have a positive impact?
    Harris, David C. H.
    Dupuis, Sophie
    Couser, William G.
    Feehally, John
    [J]. KIDNEY INTERNATIONAL SUPPLEMENTS, 2012, 2 (03) : 275 - 278
  • [22] A population-based study measuring the prevalence of chronic kidney disease among adults in West Malaysia
    Hooi, Lai Seong
    Ong, Loke Meng
    Ahmad, Ghazali
    Bavanandan, Sunita
    Ahmad, Noor Ani
    Naidu, Balkish M.
    Mohamud, Wan Nazaimoon W.
    Yusoff, Muhammad Fadhli M.
    [J]. KIDNEY INTERNATIONAL, 2013, 84 (05) : 1034 - 1040
  • [23] High prevalence of chronic kidney disease in Iran: a large population-based study
    Hosseinpanah, Farhad
    Kasraei, Farshad
    Nassiri, Amir A.
    Azizi, Fereidoun
    [J]. BMC PUBLIC HEALTH, 2009, 9
  • [24] The Urban Crisis in Sub-Saharan Africa: A Threat to Human Security and Sustainable Development
    Hove, Mediel
    Ngwerume, Emmaculate Tsitsi
    Muchemwa, Cyprian
    [J]. STABILITY-INTERNATIONAL JOURNAL OF SECURITY AND DEVELOPMENT, 2013, 2 (01):
  • [25] Prevalence and risk factors of chronic kidney disease in the Thai adult population: Thai SEEK study
    Ingsathit, Atiporn
    Thakkinstian, Ammarin
    Chaiprasert, Amnart
    Sangthawan, Pornpen
    Gojaseni, Pongsathorn
    Kiattisunthorn, Kriwiporn
    Ongaiyooth, Leena
    Vanavanan, Somlak
    Sirivongs, Dhavee
    Thirakhupt, Prapaipim
    Mittal, Bharati
    Singh, Ajay K.
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2010, 25 (05) : 1567 - 1575
  • [26] Organ Trafficking: Global Solutions for a Global Problem
    Jafar, Tazeen H.
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2009, 54 (06) : 1145 - 1157
  • [27] Serum creatinine as marker of kidney function in South Asians: A study of reduced GFR in adults in Pakistan
    Jafar, TH
    Schmid, CH
    Levey, AS
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2005, 16 (05): : 1413 - 1419
  • [28] Global Trends in Rates of Peritoneal Dialysis
    Jain, Arsh K.
    Blake, Peter
    Cordy, Peter
    Garg, Amit X.
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2012, 23 (03): : 533 - 544
  • [29] Chronic kidney disease: global dimension and perspectives
    Jha, Vivekanand
    Garcia-Garcia, Guillermo
    Iseki, Kunitoshi
    Li, Zuo
    Naicker, Saraladevi
    Plattner, Brett
    Saran, Rajiv
    Wang, Angela Yee-Moon
    Yang, Chih-Wei
    [J]. LANCET, 2013, 382 (9888) : 260 - 272
  • [30] Substandard drugs: a potential crisis for public health
    Johnston, Atholl
    Holt, David W.
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 78 (02) : 218 - 243